Meeting Details
- Meeting Date: Friday, November 13, 2026
- Purpose: Board meeting to consider multiple agenda items
Agenda Items
1. Consider, approve and take on record the Unaudited Financial Results (Standalone and Consolidated) of the Company for the half year ended September 30, 2026, along with the Limited Review Report of the Statutory Auditors thereon
2. Consider and approve the proposal for alteration of the Memorandum of Association of the Company, subject to the approval of the members of the Company
3. Consider and approve the convening of an Extraordinary General Meeting of the members of the Company and the Notice thereof
4. Transact such other business as may be deemed necessary with the permission of the Chair
Trading Window Closure
- Trading Window closure period: From Thursday, October 1, 2026 until 48 hours after the declaration of the Unaudited Financial Results for the half year ended September 30, 2026
- Regulatory basis: SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders
Additional Information
- Document signed by Antaryami Nayak, MD & CEO (DIN: 07232463)
- Date of disclosure: November 03, 2026